Allgar, Victoria Louise orcid.org/0000-0002-5228-2623, Chen, Hong, Currow, David et al. (2 more authors) (2018) Psychometric properties of the Needs Assessment Tool - Progressive Disease Cancer in UK Primary Care Journal of Pain and Symptom Management. Journal of pain and symptom management. ISSN 0885-3924
Abstract
Background: The assessment of patients’ needs for care is a critical step in achieving patient-centred cancer care. Tools can be used to assess needs and inform care planning. The Needs Assessment Tool: Progressive Disease- Cancer (NAT: PD-C) is an Australian oncology clinic tool for assessment by clinicians of patients’ and carers’ palliative care needs. This has not been validated in the UK Primary Care setting. Aim: To test the psychometric properties and acceptability of a UK primary-care adapted NAT:PD-C. Design: Reliability: NAT: PD-C -guided video-recorded consultations were viewed, rated and re-rated by clinicians. Weighted Fleiss’ kappa and PABAK statistics were used. Construct: During a consultation GPs used NAT:PD-C, patient measures (Edmonton Symptom Assessment Scale; Research Utilisation Group Activities of Daily Living; Palliative care Outcome Score; Australian Karnofsky Performance Scale) and carer measures (Carer Strain Index; Carer Support Needs Assessment Tool). Kendall’s Tau-b was used. Setting/Participants: General medical practitioners (GPs), nurses, patients and carers were recruited from primary care practices. Results: Reliability: All patient wellbeing items and 4/5 items in the carer/family ability to care section showed adequate inter-rater reliability. There was moderate test-retest reliability for 5/6 in the patient wellbeing section and 5/5 in the carer/family ability to care section. Construct: There was at least fair agreement for 5/6 of patient wellbeing items; high for daily living (Kendall’s Tau-b =0.57, p<0.001). The NAT:PD-C has adequate carer construct validity (5/8) with strong agreement for 2/8. Over three-quarters of GPs considered the NAT: PD-C to have high acceptability. Conclusion: The NAT PD-C is reliable, valid and acceptable the UK primary care setting. Effectiveness in reducing patient and carer unmet need and issues regarding implementation are yet to be evaluated.
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2018 American Academy of Hospice and Palliative Medicine.Published by Elsevier Inc. All rights reserved. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. |
Dates: |
|
Institution: | The University of York |
Academic Units: | The University of York > Faculty of Sciences (York) > Hull York Medical School (York) |
Depositing User: | Pure (York) |
Date Deposited: | 05 Jul 2018 08:10 |
Last Modified: | 16 Oct 2024 14:53 |
Published Version: | https://doi.org/10.1016/j.jpainsymman.2018.07.002 |
Status: | Published online |
Refereed: | Yes |
Identification Number: | 10.1016/j.jpainsymman.2018.07.002 |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:132951 |